ISSN: 1007-385X

Journal Home

Journal Guideline

Chinese Journal of Cancer Biotherapy Q4 Unclaimed

China

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Chinese Journal of Cancer Biotherapy is a journal indexed in SJR in Pharmacology and Molecular Medicine with an H index of 5. It has an SJR impact factor of 0,108 and it has a best quartile of Q4. It has an SJR impact factor of 0,108.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q4) Molecular Medicine (Q4) Pharmacology (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,108

SJR Impact factor

5

H Index

114

Total Docs (Last Year)

389

Total Docs (3 years)

4188

Total Refs

33

Total Cites (3 years)

389

Citable Docs (3 years)

0.11

Cites/Doc (2 years)

36.74

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Pharmaceutical Chemistry Journal Q4
Expert Review of Precision Medicine and Drug Development Q4
Adverse Drug Reaction Bulletin Q4
Annals of Cancer Research and Therapy Q4
Journal of Pharmacology and Pharmacotherapeutics Q4

Compare this journals